Nevirapine Side Effects: What to Expect and When to Call Your Doctor

Nevirapine is an effective HIV medication, but it carries some of the most serious safety warnings in the NNRTI drug class. Two boxed warnings — the FDA's strongest safety alert — are attached to its label: one for potentially fatal liver damage and one for life-threatening skin reactions. Understanding these risks and knowing the early warning signs can be lifesaving. This guide explains what to expect, what to watch for, and when to seek immediate help.

The Two Boxed Warnings: Understanding the Biggest Risks

Boxed Warning 1: Hepatotoxicity (Liver Damage)

Nevirapine can cause severe, life-threatening, and sometimes fatal liver damage — particularly in the first 18 weeks of treatment. The first 6 weeks carry the highest risk. Women with CD4 counts above 250 cells/mm³ and men with CD4 counts above 400 cells/mm³ at the time of starting nevirapine are at increased risk. People with pre-existing hepatitis B or C infection also face elevated risk.

Signs of liver damage — call your doctor immediately if you experience:

Yellowing of the skin or whites of the eyes (jaundice)

Dark (tea-colored) urine or pale/clay-colored stools

Nausea, loss of appetite, or vomiting

Pain in the upper right side of your abdomen

Extreme fatigue or weakness, especially combined with other symptoms

Boxed Warning 2: Severe Skin Reactions

Nevirapine can cause severe, life-threatening skin reactions including Stevens-Johnson syndrome (SJS), toxic epidermal necrolysis (TEN), and hypersensitivity reactions. Most severe rashes occur during the first 6 weeks of treatment. Women are at higher risk of skin reactions than men.

Signs of serious skin reactions — get emergency help immediately if you have:

A rash that blisters, peels, or causes raw skin

Painful red or dark skin that looks burned

Mouth sores, eye redness or pain, or genital lesions

Fever, sore throat, or swelling of the face or lips along with a rash

Critical rule: If nevirapine is stopped due to a serious liver or skin reaction, you should never restart it. Your doctor will not re-challenge you with this medication.

Common Side Effects of Nevirapine

Not every side effect is an emergency. Most patients tolerate nevirapine without severe problems, especially when the 14-day lead-in dose (200 mg once daily) is properly followed. Common, usually manageable side effects include:

Rash: A mild rash is common, especially early in treatment. Report any rash to your provider immediately — they will assess whether it's benign or serious

Headache: Often mild and tends to diminish over time

Nausea: More common in the first weeks of treatment; taking with food can help

Fatigue: Feeling tired is common with many HIV medications

Fat redistribution: Body fat changes (gaining in the belly or back, losing in the arms, legs, or face) are associated with antiretroviral therapy in general, including nevirapine

Liver enzyme elevations: Mild elevations in liver enzymes (AST, ALT) may occur and are monitored with regular blood tests

The 14-Day Lead-In: Why It Matters for Side Effects

One unique aspect of nevirapine dosing is the mandatory 14-day lead-in period. You start at 200 mg once daily for 14 days before increasing to 200 mg twice daily (or 400 mg extended-release once daily). This gradual start is clinically proven to reduce the frequency of rash. If you develop a rash during the lead-in period, do not increase your dose until the rash resolves and your provider has evaluated it.

Immune Reconstitution Inflammatory Syndrome (IRIS)

When starting HIV treatment, your immune system can recover and react to previously hidden infections — a phenomenon called IRIS. Symptoms may appear weeks or months after starting nevirapine and can include fever, swollen lymph nodes, or worsening of pre-existing infections. This is not a side effect of nevirapine specifically but of antiretroviral therapy in general. Report any new symptoms to your provider.

39,049+ patients found their medications in stock

39K+

Find Nevirapine In Stock Today →

Monitoring Schedule During Nevirapine Therapy

Your provider will schedule frequent blood tests (liver function tests, viral load, CD4 count) during the first 18 weeks of nevirapine therapy. This intensive monitoring period is specifically designed to catch liver problems or severe skin reactions early. Do not skip these appointments — early detection is key to preventing serious harm.

Also review: nevirapine drug interactions — as drug interactions can worsen or mask side effects.